CSIMarket
 
Safeguard Scientifics Inc  (SFE)
Other Ticker:  
 
    Sector  Financial    Industry Investment Services
   Industry Investment Services
   Sector  Financial
 
Price: $0.4550 $-0.20 -30.215%
Day's High: $0.685 Week Perf: -28.92 %
Day's Low: $ 0.40 30 Day Perf: -39.33 %
Volume (M): 899 52 Wk High: $ 2.19
Volume (M$): $ 409 52 Wk Avg: $1.29
Open: $0.65 52 Wk Low: $0.40



 Market Capitalization (Millions $) 7
 Shares Outstanding (Millions) 16
 Employees 30
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Safeguard Scientifics Inc

Safeguard’s charter is to build value in early- and growth-stage businesses by providing capital as well as strategic, operational and management resources. Safeguard participates in early- and growth-stage financings. Our vision is to be the preferred capital source for entrepreneurs and management teams in well-defined industry sectors. Throughout this document, we use the term “partner company” to generally refer to those companies in which we have an equity interest and in which we are actively involved, influencing development through board representation and management support, in addition to the influence we exert through our equity ownership. From time to time, in addition to these partner companies, we also hold relatively small equity interests in other enterprises where we do not exert significant influence and do not participate in management activities. In some cases, these interests relate to former partner companies and in some cases they relate to entities which may later become partner companies.

Healthcare — companies focused principally on medical technology (“MedTech”), including diagnostics and devices; and healthcare technology (“HealthTech”). Within these areas, Safeguard targets companies that have lesser regulatory risk and have achieved or are near commercialization; and

Technology — companies focused principally on digital media; financial technology (“FinTech”); and enterprise software including mobile technology, cloud, “Internet of Things” and big data. Within these areas, Safeguard targets companies that have transaction-enabling applications with a recurring revenue stream.


Deploy capital in companies within our strategic focus;

Build value in partner companies by developing strong management teams, growing the companies organically and through acquisitions, and positioning the companies for liquidity at premium valuations;

Realize the value of partner companies through selective, well-timed exits to maximize risk-adjusted value; and

Provide the tools needed for investors to fully recognize the shareholder value that has been created by our efforts.

To meet our strategic objectives during 2016, Safeguard will continue to focus on:

Finding opportunities to deploy our capital in additional partner companies within our target sectors;

Helping partner companies achieve additional market penetration, revenue growth, cash flow improvement and growth in long-term value; and

Realizing value in our partner companies if and when we believe doing so will maximize value for our shareholders.

Founded in 1953, Safeguard has a distinguished track record of building market leaders by providing capital and operational support to entrepreneurs across an evolving and innovative spectrum of industries. Today, Safeguard principally targets healthcare companies focusing on medical technology and healthcare technology; and technology companies focusing on financial technology, digital media, and enterprise software including mobile technology, cloud, “Internet of Things” and big data.
As a visionary for the development of early- and growth-stage healthcare and technology companies, Safeguard is a proven partner for entrepreneurs looking to accelerate growth and build long-term value in their businesses. Leveraging Safeguard’s history of building market leaders, along with our team’s collective operational expertise and successful entrepreneurial endeavors, Safeguard has built a powerful — and actionable — platform of resources to support our partner companies with the strategies and relationships that are most vital for success. We provide value that extends beyond capital and work as a team to foster growth.

Safeguard’s go-to-market strategy, marketing and sourcing activities within our target sectors (Healthcare and Technology) are designed to generate a large volume of high-quality opportunities to acquire significant shareholder positions in partner companies. Our principal focus is to acquire positions in early- and growth-stage companies with attractive growth prospects in the healthcare and technology sectors. Generally, we prefer to deploy capital into companies:

operating in large and/or growing markets;

with barriers to entry by competitors, such as proprietary technology and intellectual property, or other competitive advantages;

with initial capital requirements between $5 million and $15 million, and follow-on financing needs of between $5 million and $10 million, with the total anticipated deployment of up to $25 million from Safeguard; and

with a compelling growth strategy.
Our sourcing efforts are targeted primarily in the eastern United States. However, in-bound deal leads generate opportunities throughout the United States, and we do not limit our sourcing to a particular geographic area within the United States. Leads come from a variety of sources, including investment bankers, syndication partners, existing partner companies and advisory board members.


In Healthcare, we currently target companies principally in MedTech and HealthTech that have lesser regulatory risk and have achieved or are near commercialization.
In Technology, we currently target companies principally in digital media, FinTech, and enterprise software that have transaction-enabling applications with a recurring revenue stream.

We believe there are many opportunities within these business models and vertical markets, and our sourcing activities are focused on finding candidate companies and evaluating how well they align with our criteria. However, we recognize we may have difficulty identifying candidate companies and completing transactions on terms we believe appropriate. As a result, we cannot be certain how frequently we will enter into transactions with new or existing partner companies.



   Company Address: 150 N. Radnor Chester Road Radnor 19087 PA
   Company Phone Number: 293-0600   Stock Exchange / Ticker: NASDAQ SFE
   


Customers Net Income grew by SFE's Customers Net Profit Margin grew to

1.54 %

20.02 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BEN   -3.55%    
BLK   -3.54%    
GS   -0.98%    
KKR   -4.06%    
MS        1.05% 
SNEX   -1.61%    
• View Complete Report
   



Announcement

Safeguard Scientifics Plans to Voluntarily Delist from NASDAQ Amidst Declining Revenue and Costs for Its Corporate Clients

Published Mon, Jan 22 2024 9:30 PM UTC

Radnor, PA ?? On January 22, 2024, Safeguard Scientifics, Inc. (NASDAQ: SFE), a provider of capital and relevant expertise for digital healthcare and technology companies, announced its intention to voluntarily delist its shares of common stock from trading on The Nasdaq Stock Market LLC. This strategic maneuver aligns with its previously announced goal to deregister its com...

Safeguard Scientifics Inc

Safeguard Scientifics Inc. Defies Adversity, Surpasses Expectations in Recent Fiscal Period

Safeguard Scientifics Inc, a company in the Investment Services sector, has shown a significant improvement in its financial performance for the period ending September 30, 2023. The company reported earnings per share (EPS) of $0.06 per share, compared to a loss of $-0.19 per share in the same period last year. Additionally, the company's EPS turned positive from a loss of $-0.18 per share in the prior reporting period.
While Safeguard Scientifics Inc experienced a decline in revenue, with a decrease of -13.913% to $0.20 million compared to $0.23 million in the corresponding reporting period a year ago, it is important to note that the remainder of the Investment Services sector recorded a 3.33% rise in top-line revenue relative to the same period last year. The sequential revenue also experienced a decline of -20.482% from $0.25 million.

Safeguard Scientifics Inc

Safeguard Scientifics Inc Faces Major Shortfall in Q2 2023 with Revenue Plummeting 84.4% and Shares Now Up 15% from Bottom

During the past 5 trading days, Safeguard Scientifics Inc (Safeguard) shares experienced a decline of 0%. This downward trend has contributed to the company's year-to-date performance, which now stands at -48.68%. Additionally, it is worth noting that Safeguard's shares are currently trading 15% above their 52-week low.
The recent decrease in Safeguard's share value can be attributed to the release of their second-quarter financial report for the year 2023. As an investment services company, Safeguard Scientifics Inc experienced a disastrous quarter as their revenue dwindled by a significant 84.428% to only $0.25 million. The company also reported a per-share shortfall of $-0.18, which represents a substantial increase compared to the same reporting season in the previous year.






 

Safeguard Scientifics Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com